ViVac Pharma
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jerusalem, Jerusalem, IsraelWebsite
www.vivacpharma.comRevenue
<$5 MillionIndustry
About ViVac Pharma
ViVac Pharma Org Chart
Is ViVac Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ViVac Pharma recently announced quarterly report
Check out if ViVac Pharma is spiking on competitors!
Product Launch: Get notified when ViVac Pharma launches new products
Website visits: Recent activity has been detected on your website
Check if ViVac Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at ViVac Pharma
Funding: Get notified immidiatlly once ViVac Pharma has new funding data
Click to see if ViVac Pharma had a recent Job posting/layoffs
ViVac Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
ViVac Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ViVac Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ViVac Pharma.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ViVac Pharma
Our mission focuses on pioneering safe, scalable, and powerful immunotherapies that harness the body’s full immune potential against cancer, utilizing world-class expertise in Synthetic Biology and Lipid Nanoparticles with a next-gen modular platform mimicking natural viral infections without the risks.... Read More
